88
Views
42
CrossRef citations to date
0
Altmetric
Original Research

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

, , , , , , , , , & show all
Pages 1715-1718 | Published online: 16 Sep 2015

Figures & data

Figure 1 Change in mean central foveal thickness (µm).

Figure 1 Change in mean central foveal thickness (µm).

Figure 2 Change in mean logMAR visual acuity.

Figure 2 Change in mean logMAR visual acuity.

Figure 3 This 78-year-old woman had long-standing diabetes with a recent HbA1c of 7.5%.

Notes: (A) After four bevacizumab injections, the right eye had persistent center-involving diabetic macular edema with a CFT of 516 mm and large cystoid spaces. (B) The CFT decreased to 455 mm after one aflibercept injection. (C) After six aflibercept injections, the CFT was 357 mm and the cystoid spaces had resolved, although a hyperreflective clump of hard exudates was still seen with ellipsoid zone disruption.
Abbreviations: CFT, central foveal thickness; HbA1c, glycated hemoglobin.
Figure 3 This 78-year-old woman had long-standing diabetes with a recent HbA1c of 7.5%.